Literature DB >> 6292742

[125I]-HEAT:fifty percent of the ligand can bind to the alpha1-adrenoceptors with extremely high affinity.

H Glossmann, F Lübbecke.   

Abstract

[125]-HEAT, 125iodo-2-[Beta-(4-hydroxyphenyl)-ethyl-aminomethyl]tetralone, is a novel alpha1-adrenoceptor ligand which labels alpha1-adrenoceptors in peripheral tissues as well as in the central nervous system. Using the technique of ligand saturation by receptors, we find that only 50% of the 125I-labeled HEAT molecules bind with high affinity to receptors from a variety of tissues. This was observed with partially purified rat brain membranes and highly purified rat liver plasma membranes in the absence or presence of sodium ion (as NaCl, 150 mM) which stimulated 125I-HEAT binding, by increasing the affinity. If the bindability of [125I]-HEAT is taken into account, KD values as low as 7-8 pM (at 30 degrees C) are found in equilibrium binding experiments and optimally stimulating concentrations of sodium ion. The limited high affinity binding of [125I]-HEAT could not be explained by radiochemical impurities. Instead, we suggest that only one enantiomer of the racemic ligand is preferentially bound to the receptors with a KD in the picomolar range. Since the enantiomers are in dynamic equilibrium in solution (via keto-enol tautomerism) [125-I]-HEAT is a unique radioligand which makes it unlikely that the respective isomers can be separated by successive depletion with receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292742     DOI: 10.1007/bf00586341

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding.

Authors:  H Glossmann; P Presek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

2.  Solubilization of a mammalian beta-adrenergic receptor.

Authors:  J Kleinstein; H Glossmann; L Braun; C Konrad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

3.  [125I]-HEAT, a selective, high-affinity, high specific activity ligand for alpha 1-adrenoceptors.

Authors:  H Glossmann; F Lübbecke; P Bellemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

4.  Alternative explanation for the apparent "two-step" binding kinetics of high-affinity racemic antagonist radioligands.

Authors:  E Bürgisser; R J Lefkowitz; A DeLean
Journal:  Mol Pharmacol       Date:  1981-05       Impact factor: 4.436

5.  Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes.

Authors:  D Hoyer; G Engel; R Berthold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

6.  Equilibrium ligand binding assays using labeled substrates: nature of the errors introduced by radiochemical impurities.

Authors:  S E Builder; I H Segel
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

Review 7.  Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.

Authors:  W A Catterall
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

8.  Cation sensitivity of [125I]heat binding to alpha 1-adrenoceptors in rat cerebral cortex membranes.

Authors:  H Glossmann; F Lübbecke; P Bellemann; P Presek
Journal:  Eur J Pharmacol       Date:  1981-10-22       Impact factor: 4.432

9.  Ionic modulation of alpha-adrenoceptors.

Authors:  H Glossmann; F Lübbecke; P Bellemann; E L Sattler; G Doell
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

10.  [125I]BE 2254, a new high affinity radioligand for alpha 1-adrenoceptors.

Authors:  G Engel; D Hoyer
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

View more
  3 in total

1.  Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport.

Authors:  H Russ; B Friedgen; B Königs; C Schumacher; K H Graefe; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

2.  125I-iodipine, a new high affinity ligand for the putative calcium channel.

Authors:  D R Ferry; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

3.  Positron tomographic quantitation of neuroreceptors in human brain in vivo--with special reference to the D2 dopamine receptors in caudate nucleus.

Authors:  A Gjedde; D F Wong
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.